Lin BioScience (ROCO:6696) Retained Earnings: NT$-872.63 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6696 Lin BioScience Inc ROCO:6696
33 GF Score
Price NT$93.70
! 2 Warning Signs
View Full Analysis

What is Lin BioScience Retained Earnings?

Lin BioScience ROCO:6696 33 Retained Earnings is NT$-872.63 Mil as of Jun. 2026. GuruFocus rates ROCO:6696 with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Lin BioScience's retained earnings for the quarter that ended in Jun. 2026 was NT$-872.63 Mil.

Lin BioScience's quarterly retained earnings declined from Jun. 2025 (NT$-3,532.91 Mil) to Dec. 2025 (NT$-4,269.45 Mil) but then increased from Dec. 2025 (NT$-4,269.45 Mil) to Jun. 2026 (NT$-872.63 Mil).

Lin BioScience's annual retained earnings declined from Dec. 2023 (NT$-2,162.34 Mil) to Dec. 2024 (NT$-2,906.60 Mil) and declined from Dec. 2024 (NT$-2,906.60 Mil) to Dec. 2025 (NT$-4,269.45 Mil).


Lin BioScience  (ROCO:6696) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Lin BioScience Retained Earnings Historical Data

* Premium members only.

The historical data trend for Lin BioScience's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lin BioScience Retained Earnings Chart

Lin BioScience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,161.62 -1,475.15 -2,162.34 -2,906.60 -4,269.45

Lin BioScience Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,509.17 -2,906.60 -3,532.91 -4,269.45 -872.63
ROCO:6696
33GF Score
Lin BioScience Inc ROCO:6696
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lin BioScience Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of NT$-872.63 Mil mean?
Lin BioScience (ROCO:6696) has a Retained Earnings of NT$-872.63 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Lin BioScience and its competitors.
Is Lin BioScience's Retained Earnings too high?
Lin BioScience's current Retained Earnings is NT$-872.63 Mil. Overall, Lin BioScience has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Lin BioScience's Retained Earnings compare to VRTX and REGN?
Lin BioScience's Retained Earnings of NT$-872.63 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Lin BioScience and its competitors. Lin BioScience's current Retained Earnings is NT$-872.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lin BioScience stock overvalued right now?
Lin BioScience (ROCO:6696) has a current Retained Earnings of NT$-872.63 Mil. The current Retained Earnings is NT$-872.63 Mil. Lin BioScience's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Lin BioScience (ROCO:6696), the current Retained Earnings is NT$-872.63 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lin BioScience Business Description

Address Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110
Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.
33GF Score

Get the complete analysis for ROCO:6696

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$93.70
Price